These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20640990)

  • 1. Effect of IL-11 on glomerular expression of TGF-beta and extracellular matrix in nephrotoxic nephritis in Wistar Kyoto rats.
    Stangou M; Bhangal G; Lai PC; Smith J; Keith JC; Boyle JJ; Pusey CD; Cook T; Tam FW
    J Nephrol; 2011; 24(1):106-11. PubMed ID: 20640990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of huangkui capsule on renal inflammatory injury by intervening p38MAPK signaling pathway in rats with adriamycin-induced nephropathy].
    Zhao Q; Wan YG; Sun W; Wang CJ; Wei QX; Chen HL; Meng XJ
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(19):2926-34. PubMed ID: 23270236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-11 attenuates nephrotoxic nephritis in Wistar Kyoto rats.
    Lai PC; Cook HT; Smith J; Keith JC; Pusey CD; Tam FWK
    J Am Soc Nephrol; 2001 Nov; 12(11):2310-2320. PubMed ID: 11675407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
    Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
    J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
    Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
    J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents.
    Fujigaki Y; Sun DF; Fujimoto T; Suzuki T; Goto T; Yonemura K; Morioka T; Yaoita E; Hishida A
    Nephron; 2002 Sep; 92(1):203-12. PubMed ID: 12187104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with an antibody to VLA-1 integrin reduces glomerular and tubulointerstitial scarring in a rat model of crescentic glomerulonephritis.
    Cook HT; Khan SB; Allen A; Bhangal G; Smith J; Lobb RR; Pusey CD
    Am J Pathol; 2002 Oct; 161(4):1265-72. PubMed ID: 12368200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis.
    Wada T; Furuichi K; Sakai N; Hisada Y; Kobayashi K; Mukaida N; Tomosugi N; Matsushima K; Yokoyama H
    Am J Kidney Dis; 2001 Dec; 38(6):1169-77. PubMed ID: 11728947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis.
    Li Z; Liu X; Wang B; Nie Y; Wen J; Wang Q; Gu C
    Nephrology (Carlton); 2017 Aug; 22(8):589-597. PubMed ID: 27245114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
    Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J
    J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
    Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
    Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
    Border WA; Ruoslahti E
    Cell Differ Dev; 1990 Dec; 32(3):425-31. PubMed ID: 2099240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
    Kagami S; Border WA; Ruoslahti E; Noble NA
    Lab Invest; 1993 Jul; 69(1):68-76. PubMed ID: 8331901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-11 reduces renal injury and glomerular NF-kappa B activity in murine experimental glomerulonephritis.
    Lai PC; Smith J; Bhangal G; Chaudhry KA; Chaudhry AN; Keith JC; Tam FW; Pusey CD; Cook HT
    Nephron Exp Nephrol; 2005; 101(4):e146-54. PubMed ID: 16131809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6.
    Sheryanna A; Bhangal G; McDaid J; Smith J; Manning A; Foxwell BM; Feldmann M; Cook HT; Pusey CD; Tam FW
    J Am Soc Nephrol; 2007 Apr; 18(4):1167-79. PubMed ID: 17314328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis.
    Makibayashi K; Tatematsu M; Hirata M; Fukushima N; Kusano K; Ohashi S; Abe H; Kuze K; Fukatsu A; Kita T; Doi T
    Am J Pathol; 2001 May; 158(5):1733-41. PubMed ID: 11337371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis.
    Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S
    Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous administration of recombinant human IL-10 suppresses the development of anti-thy 1-induced glomerulosclerosis in rats.
    Rachmawati H; Beljaars L; Reker-Smit C; Bakker HI; Van Loenen-Weemaes AM; Lub-De Hooge MN; Poelstra K
    PDA J Pharm Sci Technol; 2011; 65(2):116-30. PubMed ID: 21502073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.